Clinical profile and management of patients with pediatric inflammatory multisystem syndrome - temporally associated with SARS-CoV-2 - single-center experience
European Journal of Clinical and Experimental Medicine
; 20(1):11-17, 2022.
Article
in English
| Scopus | ID: covidwho-20240827
ABSTRACT
Introduction and aim. Pediatric Inflammatory Multisystem Syndrome (PIMS-TS) is a new condition that has emerged in children during the COVID-19 pandemic. Many clinical signs and symptoms resemble those found in Kawasaki disease (KD). Material and methods. The following data were considered clinical presentation, comorbidities, laboratory findings, abnormalities in additional tests, exposure to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in the child and his family members, applied treatment and return to full health. Results. In the presented study nineteen children were analyzed. Fever was a universal finding in our group and it's mean duration was 7 days (range 5-9). Other common symptoms included abdominal pain and severe weakness (in 89.5%), rash and conjunctivitis (in 84.2%), vomiting (in 73.7%) and mucous membrane involvement (in 63.2%). In nearly half of cases, echocardiography revealed fluid in the pericardial sac and left ventricular systolic dysfunction (in 52.6% and 47.4% respectively). 21.1% of patients had coronary artery abnormalities. 26, 3% of the children required treatment with dopamine and/or milrinone. In 15.7% ICU admissions and assisted ventilation was necessary. No deaths were recorded. Conclusion. One should bear in mind that PIMS-TS can mimic KD, appendicitis and meningitis, which may pose a diagnostic challenge. © 2022 Publishing Office of the University of Rzeszow. All Rights Reserved.
Full text:
Available
Collection:
Databases of international organizations
Database:
Scopus
Type of study:
Diagnostic study
/
Prognostic study
Language:
English
Journal:
European Journal of Clinical and Experimental Medicine
Year:
2022
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS